Menu
Live News EQUITY H impact

AbbVie nears $11bn Apogee deal

AbbVie is closing in on a nearly $11 billion deal for biotech company Apogee Therapeutics

ABBV

AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics -- FT